title: CD82 gene suppression in endometrial stromal cells leads to increase of the cell invasiveness in the endometriotic milieu.
abstract: Tetraspanin CD82 is a wide-spectrum tumor metastasis suppressor that inhibits motility and invasiveness of cancer cells. Endometriosis is a benign gynecological disorder, but appears malignant behaviors including invasion, ectopic implantation and recurrence. This study is to elucidate the role of CD82 expression regulation in the pathogenesis of endometriosis. The short interfering RNA silence was established to analyze the roles of CD82, chemokine CCL2, and its receptor CCR2 in the invasiveness of endometrial stromal cells (ESCs). We have found that the mRNA and protein levels of CD82 in the primary normal ESCs from endometrium without endometriosis are significantly higher than that of the primary ESCs from eutopic endometrium and ectopic tissue. CD82 inhibits the invasiveness of ESCs by downregulating CCL2 secretion and CCR2 expression via mitogen-activated protein kinase (MAPK) and integrinβ1 signal pathway, and in turn upregulating the expression of TIMP1 and TIMP2 in an autocrine manner. The combination of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) with 17β-estradiol can promote the invasion of ESCs via suppressing CD82 expression and stimulating CCL2 secretion and CCR2 expression, and the enhanced interaction of CCL2-CCR2 recruits more macrophages into the ectopic milieu in a paracrine manner, which further downregulates CD82 expression in the ectopic ESCs. Our study has demonstrated for the first time that the abnormal lower CD82 expression in ESCs induced by TCDD and estrogen may be an important molecular basis of endometriosis pathogenesis through enhancing the CCL2 secretion and CCR2 expression and the invasion of ESCs via MAPK and integrinβ1 signal pathway.
authors.affiliation: Laboratory for Reproductive Immunology, Fudan University Shanghai Medical College, Hospital and Institute of Obstetrics and Gynecology, IBS, Shanghai 200011, People's Republic of China.
authors.forename: Ming-Qing
authors.initials: MQ
authors.lastname: Li
authors.forename: Xiao-Fan
authors.initials: XF
authors.lastname: Hou
authors.forename: Shi-Jian
authors.initials: SJ
authors.lastname: Lv
authors.forename: Yu-Han
authors.initials: YH
authors.lastname: Meng
authors.forename: Xiao-Qiu
authors.initials: XQ
authors.lastname: Wang
authors.forename: Chuan-Ling
authors.initials: CL
authors.lastname: Tang
authors.forename: Da-Jin
authors.initials: DJ
authors.lastname: Li
mesh_terms: D000328:Adult; D057134:Antibodies, Neutralizing / Q000494:pharmacology; D015153:Blotting, Western; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects; D003094:Collagen; D004338:Drug Combinations; D004715:Endometriosis / Q000235:genetics / Q000378:metabolism*; D004717:Endometrium / Q000166:cytology*; D004797:Enzyme-Linked Immunosorbent Assay; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D051861:Kangai-1 Protein / Q000235:genetics / Q000378:metabolism*; D007797:Laminin; D008875:Middle Aged; D000072317:Polychlorinated Dibenzodioxins / Q000494:pharmacology; D011509:Proteoglycans; D034741:RNA, Small Interfering; D054390:Receptors, CCR2 / Q000037:antagonists & inhibitors; D020133:Reverse Transcriptase Polymerase Chain Reaction; D017154:Stromal Cells / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*
chemical_list: D057134:Antibodies, Neutralizing; C515334:CCR2 protein, human; D004338:Drug Combinations; D051861:Kangai-1 Protein; D007797:Laminin; D000072317:Polychlorinated Dibenzodioxins; D011509:Proteoglycans; D034741:RNA, Small Interfering; D054390:Receptors, CCR2; C059485:matrigel; D004958:Estradiol; D003094:Collagen